Home › Major Depressive Disorder › Oklahoma › Edmond
Pag-aaral pangklinika para sa Major Depressive Disorder sa Edmond, OK
6 pag-aaral para sa Major Depressive Disorder ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Edmond (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Nagre-recruitPhase 3
- Conrad Clinical Research, Edmond
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Nagre-recruitPhase 3
- Conrad Clinical Research, Edmond
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Nagre-recruitPhase 3
- Clinical Research Site, Edmond
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 3
- Neurocrine Clinical Site, Edmond
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 3
- Neurocrine Clinical Site, Edmond
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Nagre-recruitPhase 4
- Clinical Research Site, Edmond
Pag-aaral para sa Major Depressive Disorder sa ibang lungsod
- New York City, NY36 pag-aaral
- Boston, MA31 pag-aaral
- Atlanta, GA25 pag-aaral
- Philadelphia, PA23 pag-aaral
- Orlando, FL19 pag-aaral
- Miami, FL18 pag-aaral
- Chicago, IL17 pag-aaral
- Tampa, FL17 pag-aaral
- San Diego, CA16 pag-aaral
- Houston, TX16 pag-aaral
- Little Rock, AR14 pag-aaral
- Austin, TX13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.